Clinical Trial Update: Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104). [Phase 1]

View source ↗

Summary

A Phase 1 master protocol trial (MTAPESTRY 104) is evaluating Anvumetostat, alone or with other therapies, in patients with advanced thoracic tumors harboring h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Anvumetostat (Anvumetostat)

Snippet

Sponsor: Amgen | Conditions: Thoracic Tumors, Non-small Cell Lung Cancer | Phase 1 | Status: RECRUITING